Identifiers
matrix metallopeptidase 1
HUGO:MMP1 hgnc_id:HGNC:7155 HGNC:7155 ENTREZ:4312 UNIPROT:P03956
matrix metallopeptidase 2
HUGO:MMP2 hgnc_id:HGNC:7166 HGNC:7166 ENTREZ:4313 UNIPROT:P08253
matrix metallopeptidase 3
HUGO:MMP3 hgnc_id:HGNC:7173 HGNC:7173 ENTREZ:4314 UNIPROT:P08254
matrix metallopeptidase 7
HUGO:MMP7 hgnc_id:HGNC:7174 HGNC:7174 ENTREZ:4316 UNIPROT:P09237
matrix metallopeptidase 8
HUGO:MMP8 hgnc_id:HGNC:7175 HGNC:7175 ENTREZ:4317 UNIPROT:P22894
matrix metallopeptidase 9
HUGO:MMP9 hgnc_id:HGNC:7176 HGNC:7176 ENTREZ:4318 UNIPROT:P14780
matrix metallopeptidase 10
HUGO:MMP10 hgnc_id:HGNC:7156 HGNC:7156 ENTREZ:4319 UNIPROT:P09238
matrix metallopeptidase 11
HUGO:MMP11 hgnc_id:HGNC:7157 HGNC:7157 ENTREZ:4320 UNIPROT:P24347
matrix metallopeptidase 12
HUGO:MMP12 hgnc_id:HGNC:7158 HGNC:7158 ENTREZ:4321 UNIPROT:P39900
matrix metallopeptidase 13
HUGO:MMP13 hgnc_id:HGNC:7159 HGNC:7159 ENTREZ:4322 UNIPROT:P45452
matrix metallopeptidase 14
HUGO:MMP14 hgnc_id:HGNC:7160 HGNC:7160 ENTREZ:4323 UNIPROT:P50281
matrix metallopeptidase 15
HUGO:MMP15 hgnc_id:HGNC:7161 HGNC:7161 ENTREZ:4324 UNIPROT:P51511
matrix metallopeptidase 16
HUGO:MMP16 hgnc_id:HGNC:7162 HGNC:7162 ENTREZ:4325 UNIPROT:P51512
matrix metallopeptidase 17
HUGO:MMP17 hgnc_id:HGNC:7163 HGNC:7163 ENTREZ:4326 UNIPROT:Q9ULZ9
matrix metallopeptidase 19
HUGO:MMP19 hgnc_id:HGNC:7165 HGNC:7165 ENTREZ:4327 UNIPROT:Q99542
matrix metallopeptidase 20
HUGO:MMP20 hgnc_id:HGNC:7167 HGNC:7167 ENTREZ:9313 UNIPROT:O60882
matrix metallopeptidase 21
HUGO:MMP21 hgnc_id:HGNC:14357 HGNC:14357 ENTREZ:118856 UNIPROT:Q8N119
matrix metallopeptidase 23A (pseudogene)
HUGO:MMP23A hgnc_id:HGNC:7170 HGNC:7170 UNIPROT:O75900
matrix metallopeptidase 23B
HUGO:MMP23B hgnc_id:HGNC:7171 HGNC:7171 ENTREZ:8510 UNIPROT:O75900
matrix metallopeptidase 24
HUGO:MMP24 hgnc_id:HGNC:7172 HGNC:7172 ENTREZ:10893 UNIPROT:Q9Y5R2
matrix metallopeptidase 25
HUGO:MMP25 hgnc_id:HGNC:14246 HGNC:14246 ENTREZ:64386 UNIPROT:Q9NPA2
matrix metallopeptidase 26
HUGO:MMP26 hgnc_id:HGNC:14249 HGNC:14249 ENTREZ:56547 UNIPROT:Q9NRE1
matrix metallopeptidase 27
HUGO:MMP27 hgnc_id:HGNC:14250 HGNC:14250 ENTREZ:64066 UNIPROT:Q9H306
matrix metallopeptidase 28
HUGO:MMP28 hgnc_id:HGNC:14366 HGNC:14366 ENTREZ:79148 UNIPROT:Q9H239
Maps_Modules
HMC:TUMOR_PROMOTING_INFLAMMATION
HMC:ACTIVATING_INVASION_AND_METASTASIS
Cancer Associated Fibroblasts / MATRIX_REGULATION
References
PMID:16572188
Activated fibroblasts also secrete increased levels of ECM-degrading proteases such as matrix metalloproteinase 2 (MMP2), MMP3 and MMP9, facilitating increased ECM turnover and altered ECM composition.
MMPs probably allow cancer cells to cross tissue boundaries and escape the primary tumour site. MMPs and other proteases also directly affect the motility and invasiveness of cancer cells. Such a direct effect has been elucidated for MMP3 (also known as stromelysin 1), which is highly expressed in fibroblasts. MMP3 directly cleaves the extracellular domain of E-cadherin, prompting normal mammary epithelial cells to disaggregate and undergo EMT, promoting cancer-cell invasiveness88. MMP1 also shows such a tumour-promoting effect. The protease-activated receptor PAR1, which is a tethered-ligand receptor, is activated by proteolytic cleavage of the extracellular domain by MMP1, promoting cancer cell migration and invasion through PAR1-dependent Ca2+ signals.
PMID:20699369
activated fibroblasts through secretion of metalloproteinases elicit in cancer cells a clear epithelial-mesenchymal transition (EMT), as well as enhancement of tumor growth and development of spontaneous metastases.
exposure of HPFs to CM from PC3 cells or to IL-6 treatment, but not to TGF-?? treatment, elicits a strong increase in MMP-2 expression and the de novo appearance of MMP-9 (Fig. 3B). In addition, treatment of HPFs with IL-6???blocking antibodies during their exposure to CM from PC3 abrogates the upregulation of MMP expression (Fig. 3B). In keeping with our findings, we observed that the MMP inhibitor ilomastat reverts both the activation of the EMT process (Fig. 3C) and the proinvasive effect elicited by PCa-AFs on PC3 cells (Fig. 3D). In contrast, the EMT induction and the increase in PC3 invasiveness induced by MFs are insensitive to MMP inhibition
PMID:22809838
CAF-induced cetuximab resistance is dependent on the matrix metalloproteinases